Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Loo Yau

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
STAR Protocols|June 7, 2021
Measuring the effect of drug treatments on primary human CD8+ T cell activation and cytolytic potentialHelen Loo Yau, Daniel D De Carvalho
Oncoimmunology|May 4, 2016
Pharmacological DNA demethylation: Implications for cancer immunotherapyDavid Roulois, Helen Loo Yau, Daniel D De Carvalho
Trends in Cell Biology|August 30, 2018
The Cancer Epigenome: Exploiting Its Vulnerabilities for ImmunotherapyHelen Loo Yau, Ilias Ettayebi, Daniel D De Carvalho
Methods in Enzymology|November 16, 2019
Methods to detect endogenous dsRNA induction and recognitionIlias Ettayebi, Helen Loo Yau, Daniel D De Carvalho
Immunity|January 13, 2021
Spliceosome-Targeted Therapies Induce dsRNA ResponsesCharles A Ishak, Helen Loo Yau, Daniel D De Carvalho
Cell|August 29, 2015
DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous TranscriptsDavid Roulois, Helen Loo Yau, Rajat Singhania, et al.
Nature|March 3, 2021
Publisher Correction: Epigenetic therapy induces transcription of inverted SINEs and ADAR1 dependencyParinaz Mehdipour, Sajid A Marhon, Ilias Ettayebi, et al.
Nature|October 22, 2020
Epigenetic therapy induces transcription of inverted SINEs and ADAR1 dependencyParinaz Mehdipour, Sajid A Marhon, Ilias Ettayebi, et al.
Cancer Immunology Research|December 21, 2014
B7-H4 expression by nonhematopoietic cells in the tumor microenvironment promotes antitumor immunityRamtin Rahbar, Albert Lin, Magar Ghazarian, et al.
British Journal of Haematology|September 19, 2023
Ratio of stemness to interferon signalling as a biomarker and therapeutic target of myeloproliferative neoplasm progression to acute myeloid leukaemiaFabíola Attié de Castro, Parinaz Mehdipour, Ankur Chakravarthy, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
STAR Protocols|June 7, 2021
Measuring the effect of drug treatments on primary human CD8+ T cell activation and cytolytic potentialHelen Loo Yau, Daniel D De Carvalho
Oncoimmunology|May 4, 2016
Pharmacological DNA demethylation: Implications for cancer immunotherapyDavid Roulois, Helen Loo Yau, Daniel D De Carvalho
Trends in Cell Biology|August 30, 2018
The Cancer Epigenome: Exploiting Its Vulnerabilities for ImmunotherapyHelen Loo Yau, Ilias Ettayebi, Daniel D De Carvalho
Methods in Enzymology|November 16, 2019
Methods to detect endogenous dsRNA induction and recognitionIlias Ettayebi, Helen Loo Yau, Daniel D De Carvalho
Immunity|January 13, 2021
Spliceosome-Targeted Therapies Induce dsRNA ResponsesCharles A Ishak, Helen Loo Yau, Daniel D De Carvalho
Cell|August 29, 2015
DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous TranscriptsDavid Roulois, Helen Loo Yau, Rajat Singhania, et al.
Nature|March 3, 2021
Publisher Correction: Epigenetic therapy induces transcription of inverted SINEs and ADAR1 dependencyParinaz Mehdipour, Sajid A Marhon, Ilias Ettayebi, et al.
Nature|October 22, 2020
Epigenetic therapy induces transcription of inverted SINEs and ADAR1 dependencyParinaz Mehdipour, Sajid A Marhon, Ilias Ettayebi, et al.
Cancer Immunology Research|December 21, 2014
B7-H4 expression by nonhematopoietic cells in the tumor microenvironment promotes antitumor immunityRamtin Rahbar, Albert Lin, Magar Ghazarian, et al.
British Journal of Haematology|September 19, 2023
Ratio of stemness to interferon signalling as a biomarker and therapeutic target of myeloproliferative neoplasm progression to acute myeloid leukaemiaFabíola Attié de Castro, Parinaz Mehdipour, Ankur Chakravarthy, et al.
Pageof 2